News
NIH researchers develop AI agent that improves accuracy of gene set analysis by leveraging expert-curated databases: Maryland Thursday, July 31, 2025, 11:00 Hrs [IST] Researchers ...
Veranova appoints Thomas Rohrer as vice president of bioconjugation: Devens, Massachusetts Wednesday, July 30, 2025, 16:00 ...
TN PTA appeals to Union Finance Minister for complete exemption of all life-saving medicines from GST: Peethaambaran Kunnathoor, Chennai Thursday, July 31, 2025, 08:00 Hrs [IST] T ...
VGGS commissioned in Gujarat: Dr. H G Koshia: Shardul Nautyal, Mumbai Thursday, July 31, 2025, 08:00 Hrs [IST] Out of the total 376 projects in ...
DBT engaged in various initiatives on alternatives to animal testing: Minister: Our Bureau, New Delhi Thursday, July 31, 2025, 08:00 Hrs [IST] Even as the Department of Biotechnol ...
SJM demands elimination of animal studies, more clarity on Biosimilar Guidelines: Gireesh Babu, New Delhi Thursday, July 31, 2025, 08:00 Hrs [IST] The Swadeshi Jagran Manch (SJM), ...
On July 24, India and the UK have signed a Free Trade Agreement in London in the presence of Indian Prime Minister Narendra Modi and UK premier Keir Starmer. The much-awaited Indo-UK FTA marks a ...
Alfasigma announces positive results from OLINGUITO phase 3 trial of filgotinib to treat adult patients with active axial spondyloarthritis: Bologna Wednesday, July 30, 2025, 18:0 ...
PCRM survey shows 91% of adults prefer a plant-based diet over injectable drugs for weight loss: Our Bureau, Bengaluru Wednesday, July 30, 2025, 17:45 Hrs [IST] Physicians Committ ...
Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium: Our Bureau, Mumbai Wednesday, July 30, 2025, 15:30 Hrs [IST] Haleon (erstwhile ...
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria: Warren, New Jersey Wednesday, July 30, 2025, 15:00 Hrs [IST] PTC Therapeuti ...
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results